title: The Residual Vaccine-preventable Burden of Rotavirus Disease.
abstract: From July 2007 to June 2015, 61% of rotavirus-positive, vaccine-eligible children were unvaccinated for rotavirus. Of these, 67% of children had received diphtheria-tetanus toxoids-acellular pertussis within the recommended age for rotavirus vaccine initiation. Improving linkage between rotavirus and diphtheria-tetanus toxoids-acellular pertussis administration may impact the residual burden of US rotavirus disease.
authors.affiliation: From the *Department of Pediatrics, Emory University School of Medicine, †Rollins School of Public Health, Emory University, ‡Children's Healthcare of Atlanta, §Department of Pathology and Laboratory Medicine, Emory University School of Medicine, and ¶Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
authors.forename: Bethany K
authors.initials: BK
authors.lastname: Sederdahl
authors.forename: Jumi
authors.initials: J
authors.lastname: Yi
authors.forename: Robert
authors.initials: R
authors.lastname: Jerris
authors.forename: Scott E
authors.initials: SE
authors.lastname: Gillespie
authors.forename: Lars
authors.initials: L
authors.lastname: Westblade
authors.forename: Colleen S
authors.initials: CS
authors.lastname: Kraft
authors.forename: Andi L
authors.initials: AL
authors.lastname: Shane
authors.forename: Ben
authors.initials: B
authors.lastname: Lopman
authors.forename: Evan J
authors.initials: EJ
authors.lastname: Anderson
mesh_terms: D006801:Humans; D007114:Immunization / Q000706:statistics & numerical data*; D007115:Immunization Schedule; D007223:Infant; D012189:Retrospective Studies; D012400:Rotavirus Infections / Q000453:epidemiology* / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D022243:Rotavirus Vaccines